Home ENGLISH Page 2

ENGLISH

Latest

Adynxx merges with Alliqua, snagging Nasdaq listing ahead of pain trials

admin -
0

Chutes & Ladders—DFCI’s Nick Haining to become VP of oncology at Merck

admin -
0

Bristol-Myers, Compugen ally to test checkpoint combinations

admin -
0

Otsuka and Proteus sign 5-year, $88M digital pill partnership

admin -
0

Carrick bags ex-Onyx cancer drug, plans pivotal trials

admin -
0

Transforming mature neurons into dopamine factories could help fight brain diseases

admin -
0

CRISPR ‘tweezers’ relocate genes to change their function

admin -
0

Ionis may have found a home for dry AMD drug with Roche in $760M...

admin -
0

Ziopharm cuts Precigen ties, narrowing its R&D focus

admin -
0

Neurocrine, Jnana team up to discover CNS drugs

admin -
0

Lee Babiss’ Gotham raises $54M to drug mRNA-modifying proteins

admin -
0

Glympse Bio premieres with $22M series A and plan for in-body disease biosensors

admin -
0

Rare disease startup Therachon to absorb GLyPharma and its SBS candidate

admin -
0

Affimed tumbles as it puts brakes on T cell engager

admin -
0

Novartis cozies up to Silicon Valley with new lab

admin -
0

Sinntaxis bags option on ex-AstraZeneca mGluR5 antagonist

admin -
0

Spark plans 2019 clinical trial of gene therapy for Pompe disease after positive mouse...

admin -
0

Akcea sets off after Alnylam’s hATTR therapy in U.S., but with a handicap

admin -
0
123...1,458Page 2 of 1,458
©